Vai al contenuto principale della pagina

Allegations of waste, fraud, and abuse in pharmaceutical pricing : financial impacts on federal health programs and the federal taxpayer : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, February 9, 2007



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Allegations of waste, fraud, and abuse in pharmaceutical pricing : financial impacts on federal health programs and the federal taxpayer : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, February 9, 2007 Visualizza cluster
Descrizione fisica: 1 online resource (iii, 186 p.) : ill
Soggetto topico: Prescription pricing - Corrupt practices - United States
Drugs - Prices - United States
Waste in government spending - United States
Soggetto non controllato: Drugs
Waste in government spending
Pricing
Medical
Political science
Business & economics
Altri titoli varianti: Allegations of waste, fraud, and abuse in pharmaceutical pricing
Titolo autorizzato: Allegations of waste, fraud, and abuse in pharmaceutical pricing  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910694354403321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui